Fatigue, ILD, IPF, Sarcoidosis
Conditions
Interventions
A cross-sectional questionnaire study. In the current study no product, medicinal product, food product or medical device will be investigated.
Sponsors
NON
Eligibility
Inclusion criteria
Inclusion criteria: Clinically stable diagnosed pulmonary fibrosis or sarcoidosis (no exacerbation/hospitalization <4 weeks) from the outpatient clinic of the Department of Respiratory Medicine (Zuyderland Heerlen or Sittard)
Exclusion criteria
Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: 1. Lack of sufficient understanding of the Dutch language; 2. Unable to complete questionnaires because of cognitive impairment;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fatigue, measured by the Cis-Fat (Attachment A), is the primary outcome. The Cis-Fat consists of eight items, scored on a 7-point Likert scale. The range of scores is from 8 (normal fatigue) to 56 (most severe fatigue), with a higher score indicating a higher level of fatigue. Scores ¡Ü26 points indicate normal fatigue, scores 27 to 35 indicate moderate fatigue and scores ¡Ý35 indicate severe fatigue | — |
Secondary
| Measure | Time frame |
|---|---|
| Demographic data (as age, gender, lungfunction, medication, etc) and questionnaires (as mMRC, VAS, CAT, EQ-5D-5L, HADS, ADIQ, KWAMOE, FCS, PAM) | — |
Contacts
Public ContactAda E.M. Bloem
Postbus 12011 3501 AA
Outcome results
None listed